Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Development of 6-amido-4-aminoisoindolyn-1,3-diones as p70S6K1 inhibitors and potential breast cancer therapeutics

Frontiers in Molecular Biosciences(2024)10.3389/fmolb.2024.1481912Source: DataRank Database

Development of 6-amido-4-aminoisoindolyn-1,3-diones as p70S6K1 inhibitors and potential breast cancer therapeutics is a research paper published in Frontiers in Molecular Biosciences (2024). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

Linked data & code

pdb doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 0.00)OA: goldTopics (22)IDs (PubMed, PMC, OpenAlex)Annotations (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Rajesh Komati ORCID,Hogyoung Kim ORCID,Jamiah Myers,Kymmia Petty,Rion Sam

Live enrichment

PubMed:39749216 PMC:PMC11694070 OpenAlex:https://openalex.org/W4405581438

NIMHD NIH HHS

Grant: U54 MD007595

NIGMS NIH HHS

Grant: UL1 GM118967

NIGMS NIH HHS

Grant: RL5 GM118966

NIGMS NIH HHS

Grant: TL4 GM118968

National Institutes of Health

Grant: 3U54MD007595-14S1

Xavier RCMI Renewal Application-Overall

National Institutes of Health

Grant: 5RL5GM118966-07

BUILD at Xavier, Project Pathways II

National Institutes of Health

Grant: 5UL1GM118967-07

BUILD at Xavier, Project Pathways II

National Institutes of Health

Grant: 8TL4GM118968-02

PROJECT PATHWAYS: STUDENT TRAINING CORE

FWCI

0.00

Citation Percentile

0.1%

goldLicense: cc-by

journalhttps://doi.org/10.3389/fmolb.2024.1481912

publisherhttps://doi.org/10.3389/fmolb.2024.1481912

publisherhttps://www.frontiersin.org/articles/10.3389/fmolb.2024.1481912/full

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39749216

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11694070

Fields of Study

PI3K/AKT/mTOR signaling in cancerProtein Kinase Regulation and GTPase SignalingProtein Tyrosine Phosphatases0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

Breast cancerCancerChemistryMedicinePharmacologyComputational biologyCancer researchBiologyInternal medicineProtein kinaseInhibitionPotencyDocking StudiesQH301-705.5Molecular BiosciencesBiology (General)